A Randomized, Single Blind, Multicenter, Therapeutic Confirmatory Study to Assess the Efficacy (Immunogenicity) and Safety of Euvichol in Healthy Adults and Children
Phase of Trial: Phase III
Latest Information Update: 05 Sep 2015
Price : $35 *
At a glance
- Drugs Cholera vaccine inactivated (Primary)
- Indications Cholera
- Focus Adverse reactions; Therapeutic Use
- Sponsors EuBiologics
- 05 Sep 2015 Results published in the Vaccine.
- 07 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 19 Jun 2014 New trial record